This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Abstract 4145775: Risk of Cardiac Adverse Events of Post-transplant Cyclophosphamide versus No Post-transplant Cyclophosphamide in Patients with Hematological Conditions Receiving Stem Cell Transplantation: A Systematic Review and Meta-Analysis., Circulation, November 2024, Wolters Kluwer Health,
DOI: 10.1161/circ.150.suppl_1.4145775.
You can read the full text:
The following have contributed to this page
